BC3 |
Function Assay |
100 µM |
24 h |
|
mediates PEL cell apoptosis |
26184999 |
BCBL1 |
Function Assay |
100 µM |
24 h |
|
mediates PEL cell apoptosis |
26184999 |
BC3 |
Function Assay |
100 µM |
24 h |
|
mediates de-phosphorylation of STAT3 correlated with HSP70 and HSF1 reduction |
26184999 |
BCBL1 |
Function Assay |
100 µM |
24 h |
|
mediates de-phosphorylation of STAT3 correlated with HSP70 and HSF2 reduction |
26184999 |
BC3 |
Function Assay |
100 µM |
24 h |
|
induces a complete autophagic flux |
26184999 |
BCBL1 |
Function Assay |
100 µM |
24 h |
|
induces a complete autophagic flux |
26184999 |
SK-MEL-28 |
Function Assay |
50/100 µM |
48 h |
DMSO |
reduces anoikis resistance |
25216522 |
MeWo |
Function Assay |
50/100 µM |
48 h |
DMSO |
reduces anoikis resistance |
25216522 |
SK-MEL-5 |
Function Assay |
50/100 µM |
48 h |
DMSO |
reduces anoikis resistance |
25216522 |
SK-MEL-2 |
Function Assay |
50/100 µM |
48 h |
DMSO |
reduces anoikis resistance |
25216522 |
B16-F0 |
Function Assay |
50/100 µM |
48 h |
DMSO |
reduces anoikis resistance |
25216522 |
TRPM2/HEK |
Function Assay |
0.1–25 µM |
15 min |
DMSO |
reduces H2O2-induced Ca2+increase in a concentration-dependent manner, and the IC50 value was 1.7 µM |
25179574 |
U937 |
Function Assay |
0.1–25 µM |
15 min |
DMSO |
reduces H2O2-induced Ca2+increase in a concentration-dependent manner, and the IC50 value was 0.4 µM |
25179574 |
TRPM2/HEK |
Function Assay |
10 µM |
40 min |
DMSO |
reduces TRPM2 activation even at high concentrations of H2O2 |
25179574 |
GL37 |
Cell Viability Assay |
0-10 µM |
48 h |
|
suppresses La expression |
24999657 |
NRK-52E |
Function Assay |
1 µM |
10 min |
|
blocks the stimulatory effect of Ang II on Pax-2 expression |
24710423 |
NRK-52E |
Function Assay |
1 µM |
10 min |
|
blocks Ang II induced CD24 expression |
24710423 |
HSC |
Function Assay |
20 μM |
1 h |
|
abrogates the differential effects of leptin or AGEs |
24614199 |
EJ |
Growth Inhibition Assay |
50/80 μM |
24/48/72 h |
|
inhibits cell growth in both time and dose dependent manner |
24587049 |
EJ |
Growth Inhibition Assay |
50/80 μM |
48 h |
|
causes S-phase arrest |
24587049 |
EJ |
Function Assay |
50/80 μM |
48 h |
|
downregulates c-Myc, cyclinD1, survivin and VEGF expressions |
24587049 |
HepG2 |
Function Assay |
50-500 μM |
60 min |
|
inhibits the IL-6-induced phosphorylation of STAT1 (Tyr705) and STAT3 (Tyr705) in a dose-dependent manner |
24242046 |
SGC7901 |
Cell Viability Assay |
0-100 μM |
24/48/72 h |
|
causes a significant reduction in cell viability dose-dependently but not time-dependently |
24151255 |
AGS |
Cell Viability Assay |
0-100 μM |
24/48/72 h |
|
causes a significant reduction in cell viability dose-dependently but not time-dependently |
24151255 |
SGC7901 |
Function Assay |
50 μM |
24/48/72 h |
|
the levels of pJAK2 began to decline at 24 hr, and rebounded at 72 hr |
24151255 |
AGS |
Function Assay |
50 μM |
24/48/72 h |
|
the levels of pJAK2 began to decline at 24 hr, and rebounded at 72 hr |
24151255 |
SGC7901 |
Function Assay |
50 μM |
24/48/72 h |
|
the cytoplasmic localization of pJAK2 (JAK2 phosphorylated at residues Tyr1007 and Tyr1008) decreased after AG490 treatment for 24 and 48 hr, but started to rebound at 72 hr |
24151255 |
AGS |
Function Assay |
50 μM |
24/48/72 h |
|
the cytoplasmic localization of pJAK2 (JAK2 phosphorylated at residues Tyr1007 and Tyr1008) decreased after AG490 treatment for 24 and 48 hr, but started to rebound at 72 hr |
24151255 |
MC3T3-E1 |
Function Assay |
50 μM |
4 h |
|
inhibits HSE-induced BMP7 and GHR protein expression |
23877734 |
7TD1-DXM |
Growth Inhibition Assay |
10 μM |
72 h |
DMSO |
inhibits cell growth |
23871159 |
7TD1-WD-90 |
Growth Inhibition Assay |
10 μM |
72 h |
DMSO |
inhibits cell growth |
23871159 |
7TD1-DXM |
Apoptosis Assay |
50 μM |
48 h |
DMSO |
induces apoptosis |
23871159 |
7TD1-WD-90 |
Apoptosis Assay |
50 μM |
48 h |
DMSO |
induces apoptosis |
23871159 |
7TD1-WD-90 |
Function Assay |
50 μM |
6 h |
DMSO |
significantly inhibits the phosphorylation of JAK2 and phosphorylation of STAT3 |
23871159 |
HepG2 |
Function Assay |
100 μM |
12/24 h |
|
inhibits STAT3 tyrosine phosphorylation |
23836400 |
RAW264.7 |
Function Assay |
50 μM |
24/48 h |
|
suppresses RANKL-induced osteoclastogenesis |
23665018 |
RAW264.7 |
Growth Inhibition Assay |
0-50 μM |
48 h |
|
inhibits cell growth dose-dependently |
23665018 |
RAW264.7 |
Growth Inhibition Assay |
0-50 μM |
48 h |
|
causes an arrest of RAW264.7 cells at the G0/G1 phase of the cell cycle |
23665018 |
RAW264.7 |
Function Assay |
50 μM |
24/48 h |
|
inhibits RANKL-induced NFATc1 expression and phosphorylation of Ser727STAT3 |
23665018 |
A549 |
Function Assay |
20/40 μM |
20 h |
|
20 μM AG490 suppresses the radiation-induced invasion of A549 cells |
23620191 |
A549 |
Function Assay |
10/20/40 μM |
24 h |
|
suppresses the radiation-induced elevation of VEGF |
23620191 |
HUVECs |
Cell Viability Assay |
20 µM |
4 h |
|
attenuates H2O2-induced cell shrinkage and improved the attachment rate of the cells |
23483946 |
HUVECs |
Apoptosis Assay |
20 µM |
4 h |
|
significantly decreases the cell apoptotic index |
23483946 |
BV-2 |
Function Assay |
20 µM |
16 h |
|
inhibits LPS-induced STAT1 phosphorylation with almost completely diminished iNOS expression |
23236370 |
NRK-52E |
Function Assay |
5 μM |
30 min |
|
attenuates Ang-(1–7)-inhibited TGF-β1 mRNA at 16 h |
23174757 |
SW620 |
Function Assay |
20 µM |
1/6 h |
|
inhibits p-STAT3 activation |
23110625 |
RPE |
Function Assay |
30 µM |
3 h |
|
inhibits the induction of p-STAT3 expression |
23094067 |
SW1116 |
Function Assay |
100 µM |
24/48/72 h |
|
decreases the expression of JAK2 and pJAK2 time-dependently |
22050790 |
HT29 |
Function Assay |
100 µM |
24/48/72 h |
|
decreases the expression of JAK2 and pJAK2 time-dependently |
22050790 |
SW1116 |
Function Assay |
100 µM |
24/48/72 h |
|
decreases the pSTAT3 levels in a time-dependent manner |
22050790 |
HT29 |
Function Assay |
100 µM |
24/48/72 h |
|
decreases the pSTAT3 levels in a time-dependent manner |
22050790 |
ARPE-19 |
Function Assay |
5 μM |
30 min |
|
inhibits JAK2 phosphorilation |
21620963 |
HSC-T6 |
Apoptosis Assay |
10 μM |
2 h |
|
inhibits the apoptosis of HSC-T6 cells induced by CDE |
21396998 |
HSC-T6 |
Function Assay |
10 μM |
2 h |
|
inhibits the expressions of pY-STAT1 and Bad induced by CDE |
21396998 |
Hep-2 |
Growth Inhibition Assay |
25-100 μM |
24/48/72 h |
|
inhibits cell growth in both time and dose dependent manner |
21309481 |
Hep-2 |
Apoptosis Assay |
50 μM |
24/48/72 h |
|
induces cell apoptosis time dependently |
21309481 |
Hep-2 |
Function Assay |
50 μM |
24/48/72 h |
|
inhibits G1 to S cell cycle transition and induces G1 cell cycle arrest |
21309481 |
Hep-2 |
Function Assay |
50 μM |
24/48/72 h |
|
downregulates the STAT3, p-STAT3 and survivin protein levels |
21309481 |
KF8 |
Function Assay |
10 μM |
1 h |
DMSO |
inhibits IL-33-induced NF-κB activation |
20940045 |
KF8 |
Function Assay |
10 μM |
1 h |
DMSO |
inhibits IL-33-induced IκBα degradation and NF-κB activation |
20940045 |
HEL |
Function Assay |
100 μM |
12-72 h |
|
inhibits the level of p-JAK2, JAK2 |
20621061 |
HEL |
Growth Inhibition Assay |
100 μM |
0-5 d |
|
reduces growth of JAK2V617F-expressing HEL cells |
20621061 |
A-172 |
Function Assay |
50/100 μM |
48 h |
|
reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion |
20589525 |
MZ-18 |
Function Assay |
50/100 μM |
48 h |
|
reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion |
20589525 |
MZ-54 |
Function Assay |
50/100 μM |
48 h |
|
reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion |
20589525 |
MZ-256 |
Function Assay |
50/100 μM |
48 h |
|
reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion |
20589525 |
MZ-304 |
Function Assay |
50/100 μM |
48 h |
|
reduces the levels of constitutively activated STAT3 in a time-dependent and dose-dependent fashion |
20589525 |
A-172 |
Growth Inhibition Assay |
50/100 μM |
48 h |
|
leads to a statistically significant reduction of cell proliferation over a time period of 48 h |
20589525 |
MZ-18 |
Growth Inhibition Assay |
50/100 μM |
48 h |
|
leads to a statistically significant reduction of cell proliferation over a time period of 48 h |
20589525 |
MZ-54 |
Growth Inhibition Assay |
50/100 μM |
48 h |
|
leads to a statistically significant reduction of cell proliferation over a time period of 48 h |
20589525 |
MZ-256 |
Growth Inhibition Assay |
50/100 μM |
48 h |
|
leads to a statistically significant reduction of cell proliferation over a time period of 48 h |
20589525 |
MZ-304 |
Growth Inhibition Assay |
50/100 μM |
48 h |
|
leads to a statistically significant reduction of cell proliferation over a time period of 48 h |
20589525 |
A-172 |
Function Assay |
50/100 μM |
48 h |
|
inhibits migration |
20589525 |
MZ-18 |
Function Assay |
50/100 μM |
48 h |
|
inhibits migration |
20589525 |
MZ-54 |
Function Assay |
50/100 μM |
48 h |
|
inhibits migration |
20589525 |
MZ-256 |
Function Assay |
50/100 μM |
48 h |
|
inhibits migration |
20589525 |
MZ-304 |
Function Assay |
50/100 μM |
48 h |
|
inhibits migration |
20589525 |
A-172 |
Function Assay |
100 μM |
48 h |
|
inhibits invasion |
20589525 |
MZ-18 |
Function Assay |
100 μM |
48 h |
|
inhibits invasion |
20589525 |
MZ-54 |
Function Assay |
100 μM |
48 h |
|
inhibits invasion |
20589525 |
MZ-256 |
Function Assay |
100 μM |
48 h |
|
inhibits invasion |
20589525 |
MZ-304 |
Function Assay |
100 μM |
48 h |
|
inhibits invasion |
20589525 |
A-172 |
Function Assay |
50/100 μM |
48 h |
|
reduces transcription of MMP genes and reduces enzymatic activity of MMPs |
20589525 |
MZ-18 |
Function Assay |
50/100 μM |
48 h |
|
reduces transcription of MMP genes and reduces enzymatic activity of MMPs |
20589525 |
MZ-54 |
Function Assay |
50/100 μM |
48 h |
|
reduces transcription of MMP genes and reduces enzymatic activity of MMPs |
20589525 |
MZ-256 |
Function Assay |
50/100 μM |
48 h |
|
reduces transcription of MMP genes and reduces enzymatic activity of MMPs |
20589525 |
MZ-304 |
Function Assay |
50/100 μM |
48 h |
|
reduces transcription of MMP genes and reduces enzymatic activity of MMPs |
20589525 |
SW1990 |
Growth Inhibition Assay |
20 μM |
24/48/72 h |
|
inhibits cell growth time dependently |
20482858 |
SW1990 |
Function Assay |
20 μM |
24 h |
|
decreases the expression of MMP-2 and VEGF mRNAs |
20482858 |
SW1990 |
Function Assay |
20 μM |
24 h |
|
decreases the intensity of p-Stat3 expression |
20482858 |
SW1990 |
Invasion Assay |
20 μM |
24 h |
|
reduces invasion of SW1990 cells |
20482858 |
THP1 |
Function Assay |
10 uM |
30 min |
|
inhibits STAT3 tyrosine phosphorylation by over 60% |
20393690 |
BMMC |
Function Assay |
0-10 μM |
15 min |
|
inhibits LTC4 release in a dose-dependent fashion with near complete inhibition at concentrations ⩾10 μM |
19835845 |
A549 |
Function Assay |
15 μm |
1 h |
|
inhibits the phosphorylation of STAT1 on tyrosine 701 was detected 15 min after SPE B treatment |
19801665 |
OVCAR-3 |
Function Assay |
10 uM |
1 h |
|
inhibits LPA-induced STAT3 phosphorylation |
19647363 |
PA-1 |
Function Assay |
10 uM |
1 h |
|
inhibits LPA-induced STAT3 phosphorylation |
19647363 |
OVCAR-3 |
Function Assay |
10 uM |
1 h |
|
inhibits LPA-induced ovarian cancer cell motility |
19647363 |
PA-1 |
Function Assay |
10 uM |
1 h |
|
inhibits LPA-induced ovarian cancer cell motility |
19647363 |
Jurkat |
Growth Inhibition Assay |
50 μM |
24/48/72 h |
|
enhances TRAIL-induces cell growth inhibition |
19564891 |
SUPT1 |
Growth Inhibition Assay |
50 μM |
24/48/72 h |
|
enhances TRAIL-induces cell growth inhibition |
19564891 |
Jurkat |
Apoptosis Assay |
50 μM |
24/48 h |
|
enhances TRAIL-induces cell apoptosis |
19564891 |
SUPT1 |
Apoptosis Assay |
50 μM |
24/48 h |
|
enhances TRAIL-induces cell apoptosis |
19564891 |